To compare outcomes of carpal tunnel release surgery in patients with and without systemic diseases, specifically focusing on symptom severity and functional limitations.
Approach:
Key Findings:
Patients with systemic diseases had worse symptom scores preoperatively (3.2 vs 2.7) and postoperatively (1.6 vs 1.3), with statistical significance.
Functional limitations were also worse in patients with systemic diseases preoperatively (3.3 vs 2.8) and postoperatively (1.8 vs 1.4), indicating significant differences.
Both groups experienced similar degrees of improvement following surgery, with mean reductions of about 1.6 points in patients with systemic diseases and 1.3 points in those without.
Interpretation:
Systemic diseases are linked to worse symptom severity and functional limitations in carpal tunnel syndrome, but surgical outcomes show similar improvement regardless of comorbidity status, suggesting that surgery is equally effective across groups.
Limitations:
Single-center study with a small sample size may limit generalizability.
Recruitment method may introduce selection bias.
Only five systemic conditions were evaluated, potentially overlooking others that could influence outcomes.
Higher body mass index in the systemic disease group may confound results and impact findings.
Conclusion:
Systemic diseases are associated with worse symptoms and functional limitations in carpal tunnel release, but improvement post-surgery is comparable across groups.
Two single-injection cross-linked hyaluronic acid formulations showed no statistically significant advantage over saline for pain or functional outcomes through 24 weeks.
Researchers urge caution in interpreting joint replacement predictors, noting that surgery reflects access and decision-making as well as disease biology.
